SHC Strangle Strategy
SHC (Sotera Health Company), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NASDAQ.
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
SHC (Sotera Health Company) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $4.41B, a trailing P/E of 37.44, a beta of 1.82 versus the broader market, a 52-week range of 10.795-19.85, average daily share volume of 3.3M, a public-listing history dating back to 2020, approximately 3K full-time employees. These structural characteristics shape how SHC stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.82 indicates SHC has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. The trailing P/E of 37.44 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.
What is a strangle on SHC?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current SHC snapshot
As of May 15, 2026, spot at $15.27, ATM IV 47.70%, IV rank 12.80%, expected move 13.68%. The strangle on SHC below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on SHC specifically: SHC IV at 47.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a SHC strangle, with a market-implied 1-standard-deviation move of approximately 13.68% (roughly $2.09 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SHC expiries trade a higher absolute premium for lower per-day decay. Position sizing on SHC should anchor to the underlying notional of $15.27 per share and to the trader's directional view on SHC stock.
SHC strangle setup
The SHC strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SHC near $15.27, the first option leg uses a $16.03 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SHC chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SHC shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $16.03 | N/A |
| Buy 1 | Put | $14.51 | N/A |
SHC strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
SHC strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on SHC. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on SHC
Strangles on SHC are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the SHC chain.
SHC thesis for this strangle
The market-implied 1-standard-deviation range for SHC extends from approximately $13.18 on the downside to $17.36 on the upside. A SHC long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current SHC IV rank near 12.80% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on SHC at 47.70%. As a Healthcare name, SHC options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SHC-specific events.
SHC strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SHC positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SHC alongside the broader basket even when SHC-specific fundamentals are unchanged. Always rebuild the position from current SHC chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on SHC?
- A strangle on SHC is the strangle strategy applied to SHC (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With SHC stock trading near $15.27, the strikes shown on this page are snapped to the nearest listed SHC chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are SHC strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the SHC strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 47.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a SHC strangle?
- The breakeven for the SHC strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current SHC market-implied 1-standard-deviation expected move is approximately 13.68%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on SHC?
- Strangles on SHC are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the SHC chain.
- How does current SHC implied volatility affect this strangle?
- SHC ATM IV is at 47.70% with IV rank near 12.80%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.